Alterola Biotech Inc (OTCMKTS:ABTI) to be the Featured Company in the PharmaInvestor Magazine
Alterola Biotech, Inc (OTCMKTS:ABTI) is set to be featured in the new PharmaInvestor Magazine May 2022 Issue. The company aims to bring next generation cannabinoid and cannabinoid-like pharmaceutical medicines to the market in the form of life changing medicines. This new title – PharmaInvestor Magazine – launched by Cannabis Investor Magazine and HempCBD Investor Magazine, is to cater to the growing cannabinoid medicine market.
Market Stats
On Wednesday, ABTI stock ended flat at $0.2140 with 7K shares, compared to its average volume of 2.3K shares. The stock moved within a range of $0.2140 – 0.2140 after opening trading at $0.2140.
Alterola Biotech, Inc. Featured in the PharmaInvestor Magazine
The PharmaInvestor Magazine aims to become the leading industry investment magazine for cannabinoid pharmaceutical and biotech investors, analysts, executives, entrepreneurs, and financial media. Content will include companies developing cannabis-based, cannabinoid and cannabinoid-like prescription medicines, their research pipelines, and intellectual property portfolios.
Subscribers can access the digital version of the magazine too, totally free of cost, for the first year. All they have to do is sign up using their email address. The Alterola Biotech Inc. feature can be found by visiting the website – www.cannainvestormag.com, in the first half of May 2022.
The cannabinoid pharmaceutical and biotech sectors have everything investors could ask for in terms of sophisticated approaches, strong teams, clear business models, and first mover advantages. With 120,000 subscribers for their current magazines, the new PharmaInvestor Magazine will build on CannaInvestor Magazine’s existing audience reach.
Key Quote
Tim Rogers, Executive Chairman states, “Over the past year we have reached major milestones and made significant progress in the development of the Company. PharmaInvestor Magazine will assist us in increasing our exposure to its investor audience, so they can perform their due diligence, understand the sector clearly, make an informed investment decision, and invest in Alterola with confidence, should they wish. It’s difficult for those who do not know our sector well to be aware of new and emerging innovative companies. The PharmaInvestor Magazine is an opportunity to educate investors and give them early access to Alterola and other great companies.”
Traders Corner
ABTI stock is trading below the 20-Day and 50-Day Moving averages of $0.22 and $0.22 respectively. Moreover, the stock is trading below the 200-Day moving average of $0.8528.
